Advertisement
Screener

Clovis Oncology, Inc. Forms 3, 4 and 5: Preferred Stock

Clovis Oncology, Inc. Forms 3, 4 and 5: Preferred Stock

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2012-03-22: Reporting owner KLINGENSTEIN PAUL H; Form 3; Security Series A-1 Preferred Stock; Transaction Holding.
  • 2012-03-22: Reporting owner KLINGENSTEIN PAUL H; Form 3; Security Series A-1 Preferred Stock; Transaction Holding.
  • 2012-03-22: Reporting owner KLINGENSTEIN PAUL H; Form 3; Security Series A-2 Preferred Stock; Transaction Holding.
  • 2012-03-22: Reporting owner KLINGENSTEIN PAUL H; Form 3; Security Series A-2 Preferred Stock; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2012-03-22
holding as of filing
KLINGENSTEIN PAUL H
Director
3Series A-1 Preferred Stock
Derivative · Indirect · By Aberdare Ventures IV, L.P.
Holdingno price filed2012-03-22
2012-03-22
holding as of filing
KLINGENSTEIN PAUL H
Director
3Series A-1 Preferred Stock
Derivative · Indirect · By Aberdare Partners IV, L.P.
Holdingno price filed2012-03-22
2012-03-22
holding as of filing
KLINGENSTEIN PAUL H
Director
3Series A-2 Preferred Stock
Derivative · Indirect · By Aberdare Ventures IV, L.P.
Holdingno price filed2012-03-22
2012-03-22
holding as of filing
KLINGENSTEIN PAUL H
Director
3Series A-2 Preferred Stock
Derivative · Indirect · By Aberdare Partners IV, L.P.
Holdingno price filed2012-03-22
2012-03-22
holding as of filing
KLINGENSTEIN PAUL H
Director
3Series B Preferred Stock
Derivative · Indirect · By Aberdare Ventures IV, L.P.
Holdingno price filed2012-03-22
2012-03-22
holding as of filing
KLINGENSTEIN PAUL H
Director
3Series B Preferred Stock
Derivative · Indirect · By Aberdare Partners IV, L.P.
Holdingno price filed2012-03-22